SEI Investments’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-788
Closed -$28K 2647
2022
Q1
$28K Buy
788
+42
+6% +$5.54K ﹤0.01% 2562
2021
Q4
$96K Sell
746
-355
-32% -$83.8K ﹤0.01% 2542
2021
Q3
$261K Sell
1,101
-85
-7% -$24.3K ﹤0.01% 2363
2021
Q2
$513K Sell
1,186
-518
-30% -$205K ﹤0.01% 2083
2021
Q1
$918K Sell
1,704
-1,173
-41% -$578K ﹤0.01% 1789
2020
Q4
$1.58M Buy
2,877
+280
+11% +$177K ﹤0.01% 1493
2020
Q3
$1.8M Buy
2,597
+405
+18% +$316K 0.01% 1334
2020
Q2
$1.67M Sell
2,192
-36
-2% -$27.1K 0.01% 1342
2020
Q1
$1.33M Buy
2,228
+814
+58% +$793K ﹤0.01% 1332
2019
Q4
$1.61M Buy
1,414
+954
+207% +$1.04M ﹤0.01% 1439
2019
Q3
$547K Buy
+460
New +$702K ﹤0.01% 1843
2019
Q2
Sell
-303
Closed -$618K 2424
2019
Q1
$618K Buy
303
+198
+189% +$349K ﹤0.01% 1779
2018
Q4
$199K Hold
105
﹤0.01% 2032
2018
Q3
$199K Sell
105
-1,250
-92% -$2.58M ﹤0.01% 1928
2018
Q2
$2.75M Buy
1,355
+920
+211% +$2.1M 0.01% 1198
2018
Q1
$963K Sell
435
-62
-12% -$158K ﹤0.01% 1433
2017
Q4
$1.15M Buy
497
+477
+2,385% +$968K ﹤0.01% 1456
2017
Q3
$36K Buy
+20
New +$27.9K ﹤0.01% 2347
2016
Q4
Sell
-194
Closed -$170K 2914
2016
Q3
$170K Buy
194
+100
+106% +$72.4K ﹤0.01% 1714
2016
Q2
$53K Sell
94
-28
-23% -$15.9K ﹤0.01% 1928
2016
Q1
$67K Sell
122
-63
-34% -$38.7K ﹤0.01% 1767
2015
Q4
$154K Buy
185
+160
+640% +$160K ﹤0.01% 1614
2015
Q3
$28K Sell
25
-10
-29% -$18.2K ﹤0.01% 2011
2015
Q2
$76K Sell
35
-229
-87% -$467K ﹤0.01% 1603
2015
Q1
$413K Sell
264
-269
-50% -$355K ﹤0.01% 1228
2014
Q4
$633K Buy
+533
New +$356K 0.01% 1076

Other funds holding BLUE

SEI Investments's BLUE Position: Q2 2022 in Review

SEI Investments sold out of bluebird bio (BLUE) in Q2 2022, closing a stake of 788 shares — an estimated $28K sold.

SEI Investments first reported a position in BLUE in Q4 2014 and held it in 26 quarters. The position peaked at $2.75M in Q2 2018. 151 funds tracked by Wall St. Rank hold BLUE as of Q2 2022.

  • SEI Investments reported no remaining bluebird bio position as of Q2 2022 after selling out during the quarter.
  • SEI Investments sold 788 bluebird bio shares in Q2 2022, an estimated $28K.
  • SEI Investments first reported a position in bluebird bio in Q4 2014 and held it in 26 quarters.
  • SEI Investments's bluebird bio position peaked at $2.75M in Q2 2018.
  • 151 funds tracked by Wall St. Rank held bluebird bio as of Q2 2022.

Based on SEI Investments's 13F filing for Q2 2022, filed 15 Aug 2022.